Biotech Co. To Face Amended Investor Suit Over COVID Test

By Sydney Price · May 1, 2023, 6:25 PM EDT

A California federal judge has declined to dismiss an amended investor complaint against a biotech company over issues with its COVID-19 test rollout, holding the revised suit plausibly alleges the defendants...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE Talis Biomedical Securities Litigation

Case Number

3:22-cv-00105

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 07, 2022